Affiliation:
1. TU Dresden
2. Massachusetts General Hospital
3. University Hospital Heidelberg
Abstract
Join Dr. Randy D'Amico and Dr. Jason Sheehan from the Journal of Neuro-Oncology for a conversation with Prof. Dr. med. Tareq Juratli, FEBNS (Technical University Dresden), Michael Parsons, PhD (Massachusetts General Hospital), and PD Dr. med. Laila König
(Universität Heidelberg) about their latest journal article, "Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors."